Diabetes mellitus is a group of metabolic disorders characterized by elevated blood glucose levels; this occurs if the body either does not produce enough of the hormone insulin or because the cells simply do not respond to be able to use it (insulin resistance).
Researchers at the Hebrew University of Jerusalem outlined cannabinoid receptors play an integral role in Type 2 diabetes as chronic inflammation has been known to cause such an imbalance in our metabolism. When the Endocannabinoid System is dysregulated, plasma 2-AG (a cannabinoid produced in the body) levels increase along with lipids and glucose, but it also reduces insulin sensitivity and high-density lipoprotein (HDL)-cholesterol in obese patients.
A phytocannabinoid such as CBD aids in the regulation of our endogenous cannabinoid 2-AG to correct this process.
Cannabinoids have been known to stabilize blood sugar levels regarding hypoglycemia and aid in the symptoms relating to nausea, irritability, low appetite, stomach pains, and stress.